PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 42 |
| 2016 | 65 |
| 2017 | 59 |
| 2018 | 67 |
| 2019 | 65 |
| 2020 | 70 |
| 2021 | 115 |
| 2022 | 89 |
| 2023 | 78 |
| 2024 | 78 |
| 2025 | 57 |
| 2026 | 21 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Int J Immunopathol Pharmacol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Integrated transcriptomic and immunogenomic analysis unravels the immunological functions and prognostic landscape of WD repeat domain 76.
- Wang Y, Zhou R, Guo S, Nan S, Duan Y, Cao L, Huang X, Yan H.
- Int J Immunopathol Pharmacol. 2026 Sep 3;40:3946320261486727. doi: 10.1177/03946320261486727.
- PMCID: PMC13542525
Wang Y, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13542525 -
Beyond antibiotic prophylaxis: A scoping review of infective endocarditis prevention in the device era.
- Aliu F, Meto A, Aliu I, Durmishi Maqedonci L, Juniku Shkololli A, Jashari L.
- Int J Immunopathol Pharmacol. 2026 Aug 11;40:3946320261476799. doi: 10.1177/03946320261476799.
- PMCID: PMC13462634
Aliu F, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13462634 -
Diagnostic preparedness for Inborn Errors of Immunity among primary care and non-immunology healthcare professionals in Kazakhstan: A cross-sectional questionnaire based study.
- Abdushukurova G, Oshibayeva A, Babayeva K, Kadyrbayeva B, Mirzabekova Z, Auyelova A.
- Int J Immunopathol Pharmacol. 2026 Aug 1;40:3946320261471029. doi: 10.1177/03946320261471029.
- PMCID: PMC13428822
Abdushukurova G, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13428822 -
Assessing tumor heterogeneity and FLOT/FOLFOX-induced alterations in cancer stem cells and cancer immune checkpoint molecules using patient-derived tumor organoids.
- Cheng CC, Su BC, Chen WY, Yu HH.
- Int J Immunopathol Pharmacol. 2026 Jul 31;40:3946320261474427. doi: 10.1177/03946320261474427.
- PMCID: PMC13428109
Cheng CC, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13428109 -
Inflammatory and neuroinjury blood biomarkers across COVID-19 severity groups in individuals with persistent neurological symptoms.
- Ruchisrisarod C, Kaewpom T, Wanthong P, Luechaipanit W, Bunprakob S, Ampoot W, Yomrat S, Hemachudha P, Supharatpariyakorn T, Thanapornsangsuth P, Tammachote R, Saraya AW.
- Int J Immunopathol Pharmacol. 2026 Jul 16;40:3946320261465568. doi: 10.1177/03946320261465568.
- PMCID: PMC13376473
Ruchisrisarod C, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13376473 -
Glycolysis and neutrophil extracellular traps in atherosclerosis: Mechanisms, association, and therapeutic strategies.
- Li L, Zhang X, Yu Z, Li X, Sun C, Hu L, Zhou K, Liu X, Yuan Y, Wu M, Liu L.
- Int J Immunopathol Pharmacol. 2026 May 27;40:3946320261450099. doi: 10.1177/03946320261450099.
- PMCID: PMC13219874
Li L, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13219874 -
Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV.
- Sorrell T, Liu F.
- Int J Immunopathol Pharmacol. 2026 May 22;40:3946320261451393. doi: 10.1177/03946320261451393.
- PMCID: PMC13198646
Sorrell T, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13198646 -
Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy.
- Zubair Butt M, Tariq Z, Imran M, Al-Eidan AA, Mahjabeen S, Fatima S, Ud Din G, Anjum S, Abdullatif M Sharif E, Ibrahim WN.
- Int J Immunopathol Pharmacol. 2026 Apr 22;40:3946320261438337. doi: 10.1177/03946320261438337.
- PMCID: PMC13111859
Zubair Butt M, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13111859 -
Apoptosis enhancement in MCF-7 cells: Synergistic effects of doxorubicin and the novel sulfonamide Zm-093.
- Pedarpour S, Zarei S, Ghafouri H.
- Int J Immunopathol Pharmacol. 2026 Apr 18;40:3946320261422036. doi: 10.1177/03946320261422036.
- PMCID: PMC13100426
Pedarpour S, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13100426 -
Primary epithelioid angiosarcoma of thyroid: A case report and review of literature.
- He X, Yang L, Yang G, Zhang W, Ma L, Wang H, Su F, Ma D, Li Y, Jiao L.
- Int J Immunopathol Pharmacol. 2026 Apr 7;40:3946320261440424. doi: 10.1177/03946320261440424.
- PMCID: PMC13065279
He X, et al.Int J Immunopathol Pharmacol. 2026.PMCID: PMC13065279